Neo-Lisstat (CAS No. 282526-98-1) is a weight-loss ingredient with excellent slimming effects, capable of eliminating excess fat from the body. Neo-Lisstat is also known as cetirizine, celestita, or cetirizine.
Dosage and Administration: It is mainly distributed locally in the gastrointestinal tract, especially in the lipid layer of the jejunum. In total jejunal samples, the area under the curve (AUC, reflecting drug exposure) of orlistat from 0-320 minutes was 5-14 times higher than that in the micelle layer, suggesting accumulation in the jejunal lipid layer. After administration of long-chain fatty acid formulations, the drug can be transported through the lymphatic system, with significantly higher concentrations in the lymph than in plasma.
Metabolism
Current research has not clarified its metabolic process in vivo, suggesting minimal or no significant metabolism.
Excretion
It is mainly excreted via feces, with approximately 97% of the unabsorbed drug excreted unchanged in feces. The excretion characteristics of the modified sustained-release formulation are consistent with those of the traditional formulation.
Product Specifications and Properties
- Molecular Weight: 401.58;
- Chemical Formula: C25H39NO3;
- CAS Registry Number: 282526-98-1;
- Purity: 99%;
- Appearance: White powder;
- Detection Method: High Performance Intensity Spectroscopy (HPLC);
- Standard: USP (United States Patent and Trademark Office)
Product Development and Application
Neo-Lisstatin is a novel weight-loss ingredient with excellent slimming effects. It can be used in compressed candies, slimming coffees, and slimming capsules. A single dose is [amount in milligrams] to eliminate excess body fat.
Why Choose Us
We provide first-hand sources; guaranteeing competitive prices and quality. We can arrange shipment on the same day after an order is placed, ensuring product quality and stable delivery, allowing for cooperative supply.
